KS

Kaustubh Srivastava

Active Director Designated Partner DIN 08204887
DIN 08204887 First appointment Dec 2018 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Kaustubh Srivastava

Data last updated:

Kaustubh Srivastava is a Designated Partner at Southcity Hospital And Trauma Centre Llp (since 2018). The company operates in Healthcare.

DIN 08204887
Primary Designation Designated Partner
Industry Healthcare
First Appointment 12 Dec 2018
Oldest Company Age 7 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner12 Dec 20182018Active

Board colleagues of Kaustubh Srivastava

Directorship timeline

Open interactive timeline →
Southcity Hospital And Trauma Centre Llp
Premium access

Shareholding and investment profile for Kaustubh Srivastava

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kaustubh Srivastava

Kaustubh Srivastava currently holds 1 directorship: Southcity Hospital And Trauma Centre Llp (Designated Partner, since 12 Dec 2018).

Kaustubh Srivastava was first appointed on 12 Dec 2018 as Designated Partner at Southcity Hospital And Trauma Centre Llp.

The current boards of Kaustubh Srivastava's companies include Daya Ram Verma (Southcity Hospital And Trauma Centre Llp), Ram Janki Verma (Southcity Hospital And Trauma Centre Llp), Sushant Verma (Southcity Hospital And Trauma Centre Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available